Central nervous system toxicity associated with liposomal amphotericin B therapy for cutaneous leishmaniasis. - Wikidata - awgldk - TriplyDB

Central nervous system toxicity associated with liposomal amphotericin B therapy for cutaneous leishmaniasis.

Central nervous system toxicity associated with liposomal amphotericin B therapy for cutaneous leishmaniasis.

http://www.wikidata.org/entity/Q37860768

about

First total synthesis of the (±)-2-methoxy-6-heptadecynoic acid and related 2-methoxylated analogs as effective inhibitors of the leishmania topoisomerase IB enzyme Long open amphotericin channels revealed in cholesterol-containing phospholipid membranes are blocked by thiazole derivative.

P2860

Q36355908-527081AA-B7B1-415D-AA91-196CCF3BE118 Q42636629-CE364C59-A524-419A-8876-422141B8829B

P2860

Central nervous system toxicity associated with liposomal amphotericin B therapy for cutaneous leishmaniasis.

http://www.wikidata.org/entity/Q37860768

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Central nervous system toxicit ...... y for cutaneous leishmaniasis.

@en

Central nervous system toxicit ...... y for cutaneous leishmaniasis.

@nl

type

label

Central nervous system toxicit ...... y for cutaneous leishmaniasis.

@en

Central nervous system toxicit ...... y for cutaneous leishmaniasis.

@nl

prefLabel

Central nervous system toxicit ...... y for cutaneous leishmaniasis.

@en

Central nervous system toxicit ...... y for cutaneous leishmaniasis.

@nl

P1433

Q37860768-01D90BFB-57B5-4145-BA4C-1E80AC13AC78

P1476

Q37860768-051CA319-10F4-4AB1-A445-561DF0A91A74

P2093

Q37860768-907DA189-23B7-42AB-BF7A-3C8C948DAD5F

Q37860768-FFFA09C3-C75E-45A4-8CAF-5969073E8679

P2860

Q37860768-2D92626D-2437-458E-B262-E87A41A87118

Q37860768-54F2E161-C403-49D5-922E-9BD63F416ECE

Q37860768-5D422ED2-4D9D-4688-95C8-318135964E62

Q37860768-616E31B5-022C-4DA1-8052-E7393809372F

Q37860768-72471300-8AB5-4C96-9B61-569EFB62D5EE

Q37860768-898BCC14-BA9A-4883-BED8-0AF17C0FFC5D

Q37860768-8B973FB6-E440-4FC1-9A6E-0652AA45F8DC

Q37860768-8F224171-31CF-48C5-9D15-D11D5865966D

Q37860768-9C47D364-61EE-4989-9586-30B2C143EF96

Q37860768-A2E48252-AC2A-4C50-94B6-1B328D43AE51

P304

Q37860768-86A4644E-7F97-45CF-8FAA-063EBAFE7D60

P31

Q37860768-2147C643-E50A-44FE-A680-42D8A15BB3B5

Q37860768-d64f9c49-1acb-4107-901f-58e094c4849e

P356

Q37860768-1D586054-B351-45F7-AD3A-77E5AC92392A

P407

Q37860768-25E0CD77-21DB-422E-86FA-6B33F5147E1B

P433

Q37860768-D81D7D46-303A-41FC-AB7C-65ECE23A4C42

P478

Q37860768-941A2CBD-E4AC-4B1F-AFA3-98A6EB4F9495

P577

Q37860768-B3E30DC7-6412-4508-A8ED-AC8040945859

P5875

Q37860768-F62DC121-82EE-488F-AB61-3B1B7FFBEDCB

P698

Q37860768-0D4B9AB1-EC60-4955-A1D7-BAC53CFC7CE1

P932

Q37860768-DE030F48-25B9-44EE-952F-E347591CF436

P356

AJTMH.2011.10-0662

P1433

American Journal of Tropical Medicine and Hygiene

P1476

Central nervous system toxicit ...... y for cutaneous leishmaniasis.

@en

P2093

Clinton K Murray

http://www.w3.org/2001/XMLSchema#string

Jessie S Glasser

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004

U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis.

Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B.

Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis

Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis.

Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits.

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group.

Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.

Delirium and depression associated with amphotericin B.

Successful treatment of childhood cutaneous leishmaniasis with liposomal amphotericin B: report of two cases.

P304

566-568

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4269/AJTMH.2011.10-0662

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50988956

http://www.w3.org/2001/XMLSchema#string

P698

21460011

http://www.w3.org/2001/XMLSchema#string

P932

3062450

http://www.w3.org/2001/XMLSchema#string